Adriana Hepner

405 total citations
14 papers, 153 citations indexed

About

Adriana Hepner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Adriana Hepner has authored 14 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Adriana Hepner's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (3 papers). Adriana Hepner is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (3 papers). Adriana Hepner collaborates with scholars based in United States, Brazil and United Kingdom. Adriana Hepner's co-authors include Michael G. Martin, José Roberto Filassi, Marcelo Zugaib, Pedro Exman, Tracey L. O’Connor, Laura Testa, Rossana Pulcineli Vieira Francisco, Kaj Blennow, Jason Porter and Henrik Zetterberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Adriana Hepner

13 papers receiving 148 citations

Peers

Adriana Hepner

ONCOL

PRM

EPIDE

PPCH

Niklas Pal Sweden

Antonino Romanzo Italy

Maxim Yankelevich United States

Catherine G. Fischer United States

D. J. Derkinderen Netherlands

Morgani Rodrigues Brazil

Alessandra Baldoni Italy

Elisa Tirtei Italy

Martin Salzmann Germany

Niklas Pal Sweden

Adriana Hepner

43 ×0.4

ONCOL

54 ×1.7

PRM

25 ×0.8

EPIDE

61 ×2.1

32 ×1.3

PPCH

Citations per year, relative to Adriana Hepner Adriana Hepner (= 1×) peers Niklas Pal

Countries citing papers authored by Adriana Hepner

Since Specialization

Citations

This map shows the geographic impact of Adriana Hepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Hepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Hepner more than expected).

Fields of papers citing papers by Adriana Hepner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Hepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Hepner. The network helps show where Adriana Hepner may publish in the future.

Co-authorship network of co-authors of Adriana Hepner

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Hepner. A scholar is included among the top collaborators of Adriana Hepner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Hepner. Adriana Hepner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Aggarwal, Charu, Parneet Cheema, Óscar Arrieta, et al.. (2023). P2.04-02 AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) + Durvalumab + Carboplatin as 1L Treatment of Advanced/mNSCLC. Journal of Thoracic Oncology. 18(11). S305–S306. 4 indexed citations

Papadopoulos, K., Débora S. Bruno, Satoru Kitazono, et al.. (2023). OA05.06 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04. Journal of Thoracic Oncology. 18(11). S55–S55. 7 indexed citations

Robinson, Clifford G., Ligang Xing, Hiroshi Tanaka, et al.. (2023). Phase 3 study of durvalumab with SBRT for unresected stage I/II, lymph-node negative NSCLC (PACIFIC-4/RTOG3515).. Journal of Clinical Oncology. 41(16_suppl). TPS8607–TPS8607. 5 indexed citations

Hepner, Adriana, Victoria Atkinson, James Larkin, et al.. (2021). Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy. European Journal of Cancer. 153. 213–222. 9 indexed citations

Versluis, Judith M., Alison M. Weppler, Lauren Brown, et al.. (2020). 1080MO The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition. Annals of Oncology. 31. S733–S734. 1 indexed citations

Hepner, Adriana, Judith M. Versluis, Camille L. Gérard, et al.. (2020). The nature and management of acquired resistance to PD1-based therapy in melanoma.. Journal of Clinical Oncology. 38(15_suppl). 10014–10014. 3 indexed citations

Hepner, Adriana, Pedro Exman, Laura Testa, et al.. (2019). Cancer During Pregnancy: The Oncologist Overview. World Journal of Oncology. 10(1). 28–34. 77 indexed citations

Hepner, Adriana, et al.. (2019). Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas. World Journal of Oncology. 10(4-5). 169–175. 26 indexed citations

Hepner, Adriana, Matteo S. Carlino, Douglas B. Johnson, et al.. (2019). Rechallenge with combination ipilimumab and anti-PD-1 (IPI+PD1) in metastatic melanoma after acquired resistance to IPI+PD1 immunotherapy. Annals of Oncology. 30. v551–v552. 1 indexed citations

10.

Porter, J. G., Adriana Hepner, Manjari Pandey, et al.. (2019). Abstract 1352: Serum neurofilament light (NfL), glial fibrillary acidic protein (GFAp) and tau protein are possible serum biomarkers for activity of brain metastases and gliomas. Cancer Research. 79(13_Supplement). 1352–1352. 1 indexed citations

11.

Hepner, Adriana, Marina Sahade, Veridiana Pires de Camargo, et al.. (2017). Treatment of advanced melanoma - A changing landscape. Revista da Associação Médica Brasileira. 63(9). 814–823. 15 indexed citations

12.

Hepner, Adriana, et al.. (2016). Risk of Melanoma among Survivors of Hematologic Malignancies. 2016. 1 indexed citations

13.

Hepner, Adriana & Maria Del Pilar Estevez-Diz. (2016). Zika Virus in a Patient With Cancer: How Much Do We Know?. Journal of Global Oncology. 2(4). 250–251. 3 indexed citations

14.

Hueb, João Carlos, et al.. (2011). A intervenção coronária percutânea melhora a função diástólica do ventrículo esquerdo em pacientes com angina estável. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 29–34.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact